United States securities and exchange commission logo December 18, 2020 Jagi Gill Chief Executive Officer Viveon Health Acquisition Corp. 3953 Holcomb Bridge Road, Suite 200 Norcross Georgia 30092 Re: Viveon Health Acquisition Corp. Form S-1 Filed December 4, 2020 File No. 333-251112 Dear Mr. Gill: We have reviewed your amended registration statement and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Form S-1 filed December 4, 2020 General 1. We note your risk factor discussion is greater than fifteen pages. Please revise to provide a section with a series of concise, bulleted or numbered statements that is no more than two pages summarizing the principal factors that make an investment in the registrant or offering speculative or risky. See Item 105(b) of Regulation S-K. You may contact Howard Efron at 202-551-3439 or Wilson Lee at 202-551-3468 if you have questions regarding comments on the financial statements and related matters. Please Jagi Gill Viveon Health Acquisition Corp. December 18, 2020 Page 2 contact David Link at 202-551-3356 or Pam Howell at 202-551-3357 with any other questions. Sincerely, FirstName LastNameJagi Gill Division of Corporation Finance Comapany NameViveon Health Acquisition Corp. Office of Real Estate & Construction December 18, 2020 Page 2 cc: Tahra Wright FirstName LastName